The development of apalutamide for the treatment of prostate cancer
Author:
Affiliation:
1. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, USA
2. Department of Oncology, Moinhos De Vento Hospital, Porto Alegre, Brazil
Funder
not funded
Publisher
Informa UK Limited
Subject
Drug Discovery
Link
https://www.tandfonline.com/doi/pdf/10.1080/17460441.2021.1829588
Reference60 articles.
1. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
2. Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet
3. Abiraterone and Increased Survival in Metastatic Prostate Cancer
4. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
5. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05
2. Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia;BMC Urology;2023-01-06
3. A straightforward access to trifluoromethylated natural products through late-stage functionalization;Natural Product Reports;2023
4. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review;Pharmacological Reviews;2022-12-12
5. Synthesis and Structure–Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents;Biomolecules;2022-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3